Cargando…
Editorial: Treatment with Dual Incretin Receptor Agonists to Maintain Normal Glucose Levels May Also Maintain Normal Weight and Control Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD)
Worldwide, metabolic dysfunction-associated fatty liver disease (MAFLD) is the most common chronic liver disease. MAFLD is associated with insulin resistance, type 2 diabetes mellitus (T2DM), obesity, hypertension, and dyslipidemia. Early diagnosis and management are vital to improving hepatic and c...
Autores principales: | Ordóñez-Vázquez, Ana Luisa, Beltrán-Gall, Sofía Murúa, Pal, Shreya C., Méndez-Sánchez, Nahum |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
International Scientific Literature, Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9479660/ https://www.ncbi.nlm.nih.gov/pubmed/36093924 http://dx.doi.org/10.12659/MSM.938365 |
Ejemplares similares
-
Screening for MAFLD: who, when and how?
por: Pal, Shreya C., et al.
Publicado: (2023) -
Impact on Prevalence of the Application of NAFLD/MAFLD Criteria in Overweight and Normal Weight Patients
por: Ordoñez-Vázquez, Ana Luisa, et al.
Publicado: (2022) -
Molecular Mechanisms Involved in MAFLD in Cholecystectomized Patients: A Cohort Study
por: Pal, Shreya C., et al.
Publicado: (2023) -
Identification of Hepatic Dendritic Cells in Liver Biopsies in Patients with Metabolic Dysfunction-Associated Fatty Liver Diseas (MAFLD) and Obesity
por: Barranco-Fragoso, Beatriz, et al.
Publicado: (2022) -
The Genome of Polymorphonuclear Neutrophils Maintains Normal Coding Sequences
por: Xiao, Fengxia, et al.
Publicado: (2013)